LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC)

CUSIP: 503459604

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / COM PAR $.0001 2
Total 13F shares
24,111,272
Share change
+2,573,451
Total reported value
$717,952,134
Put/Call ratio
34%
Price per share
$29.77
Number of holders
82
Value change
+$76,434,629
Number of buys
60
Number of sells
38

Quarterly Holders Quick Answers

What is CUSIP 503459604?
CUSIP 503459604 identifies LJPC - LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) as of Q2 2017

As of 30 Jun 2017, LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) was held by 82 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,111,272 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, FMR LLC, PERCEPTIVE ADVISORS LLC, JENNISON ASSOCIATES LLC, Consonance Capital Management LP, Broadfin Capital, LLC, STATE STREET CORP, RTW INVESTMENTS, LP, BlackRock Inc., and JANUS HENDERSON GROUP PLC. This page lists 82 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.